Epoxide hydrolases: biochemistry and molecular biology.

Epoxides are organic three-membered oxygen compounds that arise from oxidative metabolism of endogenous, as well as xenobiotic compounds via chemical and enzymatic oxidation processes, including the cytochrome P450 monooxygenase system. The resultant epoxides are typically unstable in aqueous environments and chemically reactive. In the case of xenobiotics and certain endogenous substances, epoxide intermediates have been implicated as ultimate mutagenic and carcinogenic initiators Adams et al. (Chem. Biol. Interact. 95 (1995) 57-77) Guengrich (Properties and Metabolic roles 4 (1982) 5-30) Sayer et al. (J. Biol. Chem. 260 (1985) 1630-1640). Therefore, it is of vital importance for the biological organism to regulate levels of these reactive species. The epoxide hydrolases (E.C. 3.3.2. 3) belong to a sub-category of a broad group of hydrolytic enzymes that include esterases, proteases, dehalogenases, and lipases Beetham et al. (DNA Cell Biol. 14 (1995) 61-71). In particular, the epoxide hydrolases are a class of proteins that catalyze the hydration of chemically reactive epoxides to their corresponding dihydrodiol products. Simple epoxides are hydrated to their corresponding vicinal dihydrodiols, and arene oxides to trans-dihydrodiols. In general, this hydration leads to more stable and less reactive intermediates, however exceptions do exist. In mammalian species, there are at least five epoxide hydrolase forms, microsomal cholesterol 5,6-oxide hydrolase, hepoxilin A(3) hydrolase, leukotriene A(4) hydrolase, soluble, and microsomal epoxide hydrolase. Each of these enzymes is distinct chemically and immunologically. Table 1 illustrates some general properties for each of these classes of hydrolases. Fig. 1 provides an overview of selected model substrates for each class of epoxide hydrolase.

[1]  I. Fleming,et al.  Cytochrome P450 2C is an EDHF synthase in coronary arteries. , 2000, Trends in cardiovascular medicine.

[2]  C. J. Omiecinski,et al.  Post-transcriptional regulation of human microsomal epoxide hydrolase. , 1998, Pharmacogenetics.

[3]  A. Gaedigk,et al.  Epitope mapping studies with human anti-cytochrome P450 3A antibodies. , 1996, Molecular pharmacology.

[4]  B. Borhan,et al.  Improved radiolabeled substrates for soluble epoxide hydrolase. , 1995, Analytical biochemistry.

[5]  D. Reynaud,et al.  Hepoxilin A3 formation in the rat pineal gland selectively utilizes (12S)-hydroperoxyeicosatetraenoic acid (HPETE), but not (12R)-HPETE. , 1994, The Journal of biological chemistry.

[6]  E. Vesell Genetic factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes. , 1991, Annales de genetique.

[7]  R. Armstrong,et al.  Mechanism of microsomal epoxide hydrolase. Semifunctional site-specific mutants affecting the alkylation half-reaction. , 1998, Biochemistry.

[8]  R. Armstrong,et al.  Enzyme-catalyzed detoxication reactions: mechanisms and stereochemistry. , 1987, CRC critical reviews in biochemistry.

[9]  E. Corey,et al.  Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate. , 1991, Biochimica et biophysica acta.

[10]  T. Kunkel,et al.  Symposium overview: the role of genetic polymorphism and repair deficiencies in environmental disease. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Chi‐Huey Wong,et al.  Development of selective tight-binding inhibitors of leukotriene A4 hydrolase. , 1993, Journal of medicinal chemistry.

[12]  G. Prestwich,et al.  Cyclopropyl oxiranes: reversible inhibitors of cytosolic and microsomal epoxide hydrolases. , 1985, Archives of biochemistry and biophysics.

[13]  D. Christianson,et al.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Oesch,et al.  Asp, Asp, and His Form the Catalytic Triad of Rat Soluble Epoxide Hydrolase (*) , 1996, The Journal of Biological Chemistry.

[15]  J. Depierre,et al.  Cytosolic epoxide hydrolase. , 1988, Chemico-biological interactions.

[16]  R. Holubkov,et al.  Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. , 1993, Pharmacogenetics.

[17]  L. Holmes,et al.  Phenytoin embryopathy: effect of epoxide hydrolase inhibitor on phenytoin exposure in utero in C57BL/6J mice. , 1995, Biochemical and molecular medicine.

[18]  M. Pirmohamed,et al.  Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene. , 1996, The Journal of pharmacology and experimental therapeutics.

[19]  B. Hammock,et al.  Cloning and expression of soluble epoxide hydrolase from potato. , 1994, The Plant journal : for cell and molecular biology.

[20]  D. V. Van Dyke,et al.  Differences in Phenytoin Biotransformation and Susceptibility to Congenital Malformations: A Review , 1991, DICP : the annals of pharmacotherapy.

[21]  J. Meijer,et al.  Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic Polymorphisms* , 2000, The Journal of Biological Chemistry.

[22]  D. Jerina,et al.  Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides. , 1983, Archives of biochemistry and biophysics.

[23]  B. Borhan,et al.  Characterization of the cytosolic epoxide hydrolase-catalyzed hydration products from 9,10:12,13-diepoxy stearic esters. , 1992, Archives of biochemistry and biophysics.

[24]  H. Yamazaki,et al.  Activation and detoxication of aflatoxin B1. , 1998, Mutation research.

[25]  C. Hassett,et al.  The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. , 1994, Genomics.

[26]  S. K. Yang,et al.  Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes. , 1987, Molecular pharmacology.

[27]  F. Oesch,et al.  Gene evolution of epoxide hydrolases and recommended nomenclature. , 1995, DNA and cell biology.

[28]  A. Sevanian,et al.  Cholesterol epoxide is a direct-acting mutagen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Depierre,et al.  Proliferation of peroxisomes and induction of cytosolic and microsomal epoxide hydrolases in different strains of mice and rats after dietary treatment with clofibrate. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[30]  D. Zeldin,et al.  Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. , 1993, The Journal of biological chemistry.

[31]  E. Dietze,et al.  Inhibition of epoxide hydrolase from human, monkey, bovine, rabbit and murine liver by trans-3-phenylglycidols. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

[32]  C. Hassett,et al.  Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms. , 1998, Carcinogenesis.

[33]  F. Fitzpatrick,et al.  Enzymatic hydration of leukotriene A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes. , 1985, The Journal of biological chemistry.

[34]  J. Haeggström,et al.  Structure, function, and regulation of leukotriene A4 hydrolase. , 2000, American journal of respiratory and critical care medicine.

[35]  C. von Schacky,et al.  The human leukotriene A4 hydrolase gene is expressed in two alternatively spliced mRNA forms. , 1996, The Biochemical journal.

[36]  B. Hammock,et al.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver. , 1993, Archives of biochemistry and biophysics.

[37]  Shirley Dex,et al.  JR 旅客販売総合システム(マルス)における運用及び管理について , 1991 .

[38]  S. Nigam,et al.  Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3 , 1999, FEBS letters.

[39]  F. Oesch,et al.  Rat and human liver cytosolic epoxide hydrolases: evidence for multiple forms at level of protein and mRNA. , 1990, Environmental health perspectives.

[40]  J. S. Sidhu,et al.  Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. , 1998, Biochemical pharmacology.

[41]  D. Grant,et al.  Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. , 1994, Pharmacogenetics.

[42]  E. Dietze,et al.  Spectrophotometric substrates for cytosolic epoxide hydrolase. , 1994, Analytical biochemistry.

[43]  W. S. Lee,et al.  Purification of hepoxilin epoxide hydrolase from rat liver. , 1989, The Journal of biological chemistry.

[44]  R. Busse,et al.  EDHF: a cytochrome P450 metabolite in coronary arteries. , 2000, Seminars in perinatology.

[45]  A. Sevanian,et al.  The cytotoxic and mutagenic properties of cholesterol oxidation products. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[46]  F. Oesch,et al.  Structure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. , 2000, Structure.

[47]  S. Knowles,et al.  Anticonvulsant Hypersensitivity Syndrome , 1999, Drug safety.

[48]  C. Kasper,et al.  Expression of rat microsomal epoxide hydrolase in Escherichia coli. Identification of a histidyl residue essential for catalysis. , 1993, The Journal of biological chemistry.

[49]  D. Reynaud,et al.  Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Jackson,et al.  Induction of microsomal epoxide hydrolase by nitrosamines in rat liver. Effect on messenger ribonucleic acids. , 1988, Biochemical pharmacology.

[51]  T. Fujita,et al.  Induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by a series of 4'-substituted-2,3,4,5-tetrachlorobiphenyls. , 1988, Toxicology.

[52]  J. Haeggström,et al.  Novel structural and functional properties of leukotriene A4 hydrolase. Implications for the development of enzyme inhibitors. , 1994, Advances in prostaglandin, thromboxane, and leukotriene research.

[53]  F. Oesch,et al.  Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate. , 1982, European journal of biochemistry.

[54]  B. Hammock,et al.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase , 1997, Nature Medicine.

[55]  J. Muglia,et al.  Anticonvulsant hypersensitivity syndrome. , 1995, Archives of internal medicine.

[56]  B. Hammock,et al.  Increased cholesterol epoxide hydrolase activity in clofibrate-fed animals. , 1988, Biochemical pharmacology.

[57]  J. Haeggström,et al.  Leukotriene A4 hydrolase: a critical role of glutamic acid-296 for the binding of bestatin. , 2000, The Biochemical journal.

[58]  J. Depierre,et al.  Subcellular and organ distribution of cholesterol epoxide hydrolase in the rat. , 1986, Biochimica et biophysica acta.

[59]  F. Beland,et al.  Mutagenicity of oxidized microsomal metabolites of 1-nitropyrene in Chinese hamster ovary cells. , 1990, Mutagenesis.

[60]  B. Borhan,et al.  Mechanism of Soluble Epoxide Hydrolase , 1995, The Journal of Biological Chemistry.

[61]  N. Kitteringham,et al.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. , 1988, British journal of clinical pharmacology.

[62]  F. Oesch,et al.  Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[63]  D. Jerina,et al.  Properties of liver microsomal cholesterol 5,6-oxide hydrolase. , 1985, Archives of biochemistry and biophysics.

[64]  J. Leeder,et al.  Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. , 1992, The Journal of pharmacology and experimental therapeutics.

[65]  O. Rådmark,et al.  Leukotriene A4 hydrolase: analysis of some human tissues by radioimmunoassay. , 1989, Biochimica et biophysica acta.

[66]  F. Gonzalez,et al.  Targeted Disruption of the Microsomal Epoxide Hydrolase Gene , 1999, The Journal of Biological Chemistry.

[67]  A. Elfarra,et al.  Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. , 1997, Archives of biochemistry and biophysics.

[68]  D. Jerina,et al.  Differential stereoselectivity of cytochromes P-450b and P-450c in the formation of naphthalene and anthracene 1,2-oxides. The role of epoxide hydrolase in determining the enantiomer composition of the 1,2-dihydrodiols formed. , 1985, The Journal of biological chemistry.

[69]  J. Haeggström,et al.  Leukotriene A4 hydrolase: structural and functional properties of the active center. , 1993, Journal of lipid mediators.

[70]  C. Falany,et al.  Glucocorticoid repression and basal regulation of the epoxide hydrolase promoter. , 1990, Archives of biochemistry and biophysics.

[71]  J. Evans,et al.  Cloning and characterization of the human leukotriene A4 hydrolase gene. , 1995, European journal of biochemistry.

[72]  C-Y Chen,et al.  Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma , 2000, British Journal of Cancer.

[73]  B. Hammock,et al.  Purification of microsomal epoxide hydrolase from liver of rhesus monkey: partial separation of cis- and trans-stilbene oxide hydrolase. , 1987, Archives of biochemistry and biophysics.

[74]  C. J. Omiecinski,et al.  Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. , 1997, Archives of Biochemistry and Biophysics.

[75]  A. B. Graham,et al.  Microsomal epoxide hydrolase of rat liver. Purification and characterization of enzyme fractions with different chromatographic characteristics. , 1986, The Biochemical journal.

[76]  O. Mcbride,et al.  Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. , 1988, The Journal of biological chemistry.

[77]  F. Oesch,et al.  Isolation and characterization of a cDNA encoding rat liver cytosolic epoxide hydrolase and its functional expression in Escherichia coli. , 1993, The Journal of biological chemistry.

[78]  M. Pirmohamed,et al.  Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. , 1995, Biochemical pharmacology.

[79]  D. Phillips,et al.  Further metabolism of diol-epoxides of chrysene and dibenz[a,c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysis. , 1988, Carcinogenesis.

[80]  C. J. Omiecinski,et al.  Xenobiotic microsomal epoxide hydrolase: 5' sequence of the human gene. , 1989, Biochimica et biophysica acta.

[81]  D. Jerina,et al.  7-Dehydrocholesterol 5,6 beta-oxide as a mechanism-based inhibitor of microsomal cholesterol oxide hydrolase. , 1986, The Journal of biological chemistry.

[82]  S. Rappaport,et al.  Measurement of benzene oxide in the blood of rats following administration of benzene. , 1997, Carcinogenesis.

[83]  R. Combes,et al.  Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase. , 1986, Mutagenesis.

[84]  G. Bellucci,et al.  Kinetics and stereochemistry of the microsomal epoxide hydrolase-catalyzed hydrolysis of cis-stilbene oxides. , 1994, Chirality.

[85]  B D Hammock,et al.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[86]  D. Zeldin,et al.  Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. , 1995, Archives of biochemistry and biophysics.

[87]  H. Jörnvall,et al.  Purification and initial characterization of microsomal epoxide hydrolase from the human adrenal gland. , 1994, Biochimica et biophysica acta.

[88]  E. Dietze,et al.  Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols. , 1991, Biochemical pharmacology.

[89]  H. Liu,et al.  Regulation of Leukotriene A4 Hydrolase Activity in Endothelial Cells by Phosphorylation* , 1997, The Journal of Biological Chemistry.

[90]  J. Rydström,et al.  Subcellular distribution, catalytic properties and partial purification of epoxide hydrolase in the human adrenal gland. , 1985, Chemico-biological interactions.

[91]  P. Ferrara,et al.  Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site. , 1998, The Biochemical journal.

[92]  K. Andersson,et al.  Studies on the intracellular distributions of soluble epoxide hydrolase and of catalase by digitonin-permeabilization of hepatocytes isolated from control and clofibrate-treated mice. , 1991, European journal of biochemistry.

[93]  F. Oesch,et al.  Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. , 1993, Toxicology and applied pharmacology.

[94]  H. Glatt,et al.  Genotoxicity characteristics of reverse diol-epoxides of chrysene. , 1993, Carcinogenesis.

[95]  F. Guengerich,et al.  Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxication. , 1999, Drug metabolism reviews.

[96]  F. Oesch,et al.  Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins , 1994, FEBS letters.

[97]  B. Borhan,et al.  Molecular and Biochemical Evidence for the Involvement of the Asp-333–His-523 Pair in the Catalytic Mechanism of Soluble Epoxide Hydrolase (*) , 1995, The Journal of Biological Chemistry.

[98]  G. Carlson Metabolism of styrene oxide to styrene glycol by mouse liver and lung. , 1998, Journal of toxicology and environmental health. Part A.

[99]  A. Sevanian,et al.  Catalytic properties and inhibition of hepatic cholesterol-epoxide hydrolase. , 1986, The Journal of biological chemistry.

[100]  W. Hinz,et al.  Catalytic triad of microsomal epoxide hydrolase: replacement of Glu404 with Asp leads to a strongly increased turnover rate. , 1999, The Biochemical journal.

[101]  J. Depierre,et al.  Induction of cytosolic and microsomal epoxide hydrolases in mouse liver by peroxisome proliferators, with special emphasis on structural analogues of 2-ethylhexanoic acid. , 1988, Chemico-biological interactions.

[102]  C. Hassett,et al.  Rabbit microsomal epoxide hydrolase: isolation and characterization of the xenobiotic metabolizing enzyme cDNA. , 1989, Archives of biochemistry and biophysics.

[103]  A. Elfarra,et al.  Epoxide hydrolase-dependent metabolism of butadiene monoxide to 3-butene-1,2-diol in mouse, rat, and human liver. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[104]  J. Meijer,et al.  Structural characterization of the human soluble epoxide hydrolase gene (EPHX2). , 1996, Biochemical and biophysical research communications.

[105]  A. Hinnen,et al.  Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction. , 1991, Biochemical pharmacology.

[106]  G. Carlson,et al.  Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. , 1996, Journal of toxicology and environmental health.

[107]  J. Depierre,et al.  Induction of cytosolic and microsomal epoxide hydrolases and proliferation of peroxisomes and mitochondria in mouse liver after dietary exposure to p-chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid. , 1987, Biochemical pharmacology.

[108]  M. Hamberg,et al.  Evidence for a carbocation intermediate in the enzymatic transformation of leukotriene A4 into leukotriene B4. , 1999, Advances in experimental medicine and biology.

[109]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[110]  P. Dayer,et al.  Association between lung cancer and microsomal epoxide hydrolase genotypes. , 1998, Cancer research.

[111]  M. Lieberman,et al.  Mouse leukotriene A4 hydrolase is expressed at high levels in intestinal crypt cells and splenic lymphocytes. , 1999, Gene.

[112]  F. Oesch,et al.  Purification and characterization of rat-liver cytosolic epoxide hydrolase. , 1988, European journal of biochemistry.

[113]  B. Hammock,et al.  Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[114]  F. Oesch,et al.  Rat cytosolic epoxide hydrolase. , 1986, Advances in experimental medicine and biology.

[115]  S. G. Kim,et al.  Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation. , 1998, Chemico-biological interactions.

[116]  W. Hinz,et al.  Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates. , 1997, European journal of biochemistry.

[117]  C. Pace-Asciak Hepoxilins: a review on their cellular actions. , 1994, Biochimica et biophysica acta.

[118]  S. Spielberg,et al.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.

[119]  F. Gonzalez,et al.  Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. , 1996, Biochemistry.

[120]  B. Hammock,et al.  Inhibition of epoxide hydrolases and glutathione S-transferases by 2-, 3-, and 4-substituted derivatives of 4'-phenylchalcone and its oxide. , 1987, Archives of biochemistry and biophysics.

[121]  A. A. Spector,et al.  Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. , 1999, American journal of physiology. Heart and circulatory physiology.

[122]  J. Haeggström,et al.  Evidence for a catalytic role of tyrosine 383 in the peptidase reaction of leukotriene A4 hydrolase. , 1995, European journal of biochemistry.

[123]  R. Armstrong,et al.  Microsomal and soluble epoxide hydrolases are members of the same family of C-X bond hydrolase enzymes. , 1994, Chemical research in toxicology.

[124]  J. Haeggström,et al.  Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. , 1994, Archives of biochemistry and biophysics.

[125]  F. Oesch,et al.  An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase , 1991, FEBS letters.

[126]  F. Oesch,et al.  Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats. , 1986, Biochemical pharmacology.

[127]  F. Oesch,et al.  Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase. , 1999, The Biochemical journal.

[128]  E. Jendraschak,et al.  Isolation of human promoter regions by Alu repeat consensus-based polymerase chain reaction. , 1998, Genomics.

[129]  C. Smith,et al.  Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer , 1999, British Journal of Cancer.

[130]  S. Månér,et al.  Induction of liver microsomal epoxide hydrolase, UDP-glucuronyl transferase and cytosolic glutathione transferase in different rodent species by 2-acetylaminofluorene or 3-methylcholanthrene. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[131]  J. A. Bond,et al.  Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. , 1994, Carcinogenesis.

[132]  F. Oesch,et al.  Human liver cytosolic epoxide hydrolases. , 1988, European journal of biochemistry.

[133]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[134]  B. Hammock,et al.  Molecular cloning and expression of murine liver soluble epoxide hydrolase. , 1993, The Journal of biological chemistry.

[135]  F. Oesch,et al.  Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide‐ but not from ethylene oxide‐induced DNA strand breaks , 1997, Environmental and molecular mutagenesis.

[136]  T. Komatsu,et al.  Mouse liver musomal cholesterol epoxide hydrolase: A specific inhibition of its activity by 5,6α-Imino-5α-cholestan-3α-OL☆ , 1983 .